These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15664013)

  • 21. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
    King D; Jarjoura D; McEwen HA; Askew MJ
    J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta.
    Bargman R; Huang A; Boskey AL; Raggio C; Pleshko N
    Connect Tissue Res; 2010 Apr; 51(2):123-31. PubMed ID: 20053133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility.
    Maghsoudi-Ganjeh M; Samuel J; Ahsan AS; Wang X; Zeng X
    J Mech Behav Biomed Mater; 2021 May; 117():104377. PubMed ID: 33636677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
    Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
    Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
    Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
    Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomechanical, Microstructural and Material Properties of Tendon and Bone in the Young Oim Mice Model of Osteogenesis Imperfecta.
    Chretien A; Couchot M; Mabilleau G; Behets C
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse.
    Cardinal M; Chretien A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Manicourt DH; Behets C
    Front Genet; 2021; 12():705505. PubMed ID: 34447412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infrared Spectroscopy-Determined Bone Compositional Changes Associated with Anti-Resorptive Treatment of the
    Shanas N; Querido W; Oswald J; Jepsen K; Carter E; Raggio C; Pleshko N
    Appl Spectrosc; 2022 Apr; 76(4):416-427. PubMed ID: 34643134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone material elasticity in a murine model of osteogenesis imperfecta.
    Mehta SS; Antich PP; Landis WJ
    Connect Tissue Res; 1999; 40(3):189-98. PubMed ID: 10772540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment.
    Harada D; Kashiwagi H; Ueyama K; Oriyama K; Hanioka Y; Sakamoto N; Kondo K; Kishimoto K; Izui M; Nagamatsu Y; Yamada H; Tanaka H; Namba N; Seino Y
    J Pediatr Endocrinol Metab; 2020 Nov; 33(11):1391-1397. PubMed ID: 33031051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.
    Yao X; Carleton SM; Kettle AD; Melander J; Phillips CL; Wang Y
    Ann Biomed Eng; 2013 Jun; 41(6):1139-49. PubMed ID: 23536112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
    Chen B; Li Y; Yang X; Xie D
    Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
    Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
    Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta.
    Bart ZR; Hammond MA; Wallace JM
    Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
    Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
    J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cochlear otic capsule thickness and intracortical canal porosity in the oim mouse model of osteogenesis imperfecta.
    De Paolis A; Miller BJ; Doube M; Bodey AJ; Rau C; Richter CP; Cardoso L; Carriero A
    J Struct Biol; 2021 Jun; 213(2):107708. PubMed ID: 33581284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.
    Misof K; Landis WJ; Klaushofer K; Fratzl P
    J Clin Invest; 1997 Jul; 100(1):40-5. PubMed ID: 9202055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.